Boston Scientific

Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025

Boston Scientific Corporation (NYSE: BSX) shares traded lower on Wednesday, November 19, 2025, even as a wave of fresh research, strategic partnership news and institutional ownership updates painted a largely constructive long‑term picture for the medtech giant. BSX stock price on 19 November 2025 As of late Wednesday trading, Boston Scientific stock was changing hands at around $96.6, down roughly 2.6% on the day. Intraday, BSX has traded in a range of roughly $96–$100, with volume running in the high single‑digit millions of shares. Investing.com Recent price action shows a short losing streak: BSX closed at about $99.2 on Tuesday

19 November 2025

Boston Scientific Stock Rockets on Blowout Q3 Results and Major Medical Wins

Boston Scientific’s Q3 report blew past expectations. Marlborough, MA-based Boston Scientific (NYSE:BSX) posted reported net income of $755 M ($0.51/share GAAP) and adjusted EPS of $0.75 timesunion.com chartmill.com, topping the $0.71–$0.72 analysts’ forecast. CEO Mike Mahoney called it “another exceptional quarter of strong performance” prnewswire.com, fueled by robust growth across all businesses. Total sales were $5.065 B, up 20.3% from a year ago prnewswire.com. Importantly, organic (same-currency) revenue grew 15.3%, well above the 12–14% guidance range. U.S. revenues surged ~27% in Q3 investing.com, reflecting strong demand for its interventional cardiology and MedSurg devices. Analysts highlighted that every major segment beat. The cardiovascular

22 October 2025

Earnings Reports · Investing · Market News · Medical Technology · Stocks